NRG BR007 **Effective 4/24/23, the HRQOL sub-study has met it’s accrual goal and is closed**

Study Number: NRG BR007 **Effective 4/24/23, the HRQOL sub-study has met it’s accrual goal and is closed**

Please Note:

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.

Available Sites

• Missouri Baptist Medical Center

Contact Person(s)

• Monica Russo 314-996-5868

View More Information - This link will take you to clinicaltrials.gov for specific study information including eligibility criteria. A full list of participating institutions can also be found on this page.